Exelixis (EXEL) EBT Growth (1y) (2011 - 2026)
Exelixis (EXEL) EBT Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
-88.68% |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
13.34% |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
-51.60% |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
-313.33% |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
-79.57% |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
-230.18% |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
71.54% |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Exelixis |
13.37 Bn |
12.59 Bn |
590.86 Mn |
30.14% |
| Date | Value |
|---|
| Apr 3, 2026 |
30.14% |
| Jan 2, 2026 |
36.76% |
| Oct 3, 2025 |
63.10% |
| Jul 4, 2025 |
-21.32% |
| Apr 4, 2025 |
317.50% |
| Jan 3, 2025 |
79.32% |
| Sep 27, 2024 |
2,559.93% |
| Jun 28, 2024 |
191.72% |
| Mar 29, 2024 |
2.05% |
| Dec 29, 2023 |
427.87% |
| Sep 29, 2023 |
-93.68% |
| Jun 30, 2023 |
13.42% |
| Mar 31, 2023 |
-43.35% |
| Dec 30, 2022 |
-126.63% |
| Sep 30, 2022 |
72.82% |
| Jul 1, 2022 |
-29.13% |
| Apr 1, 2022 |
4,329.73% |
| Dec 31, 2021 |
164.75% |
| Oct 1, 2021 |
240.08% |
| Jul 2, 2021 |
54.76% |
